RecruitingNCT06672497

Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients


Sponsor

University of South Carolina

Enrollment

30 participants

Start Date

Sep 7, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Participants recruited for this study will be breast cancer or gynecological cancer patients who agree to participate in an exercise study examining the effects of chemotherapy on muscle mitochondrial oxidative capacity, a measure of skeletal muscle health. Participants will ride a stationary bicycle and the quadriceps muscle will be non-invasively evaluated.


Eligibility

Sex: FEMALEMin Age: 20 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a non-invasive light-based technique called Near Infrared Spectroscopy (NIRS) to measure how well the muscles' power plants (mitochondria) are working in breast and gynecological cancer patients. Poor mitochondrial function is linked to cancer-related fatigue and reduced treatment tolerance. **You may be eligible if...** - You have been diagnosed with breast cancer or a gynecological cancer (such as ovarian, cervical, or uterine cancer) without distant spread - You can perform light cycling exercise for up to 15 minutes - Your blood counts (hemoglobin, liver enzymes) are within acceptable ranges - You have a moderate baseline level of physical activity **You may NOT be eligible if...** - Your cancer has spread to other parts of the body (metastatic) - You have significant heart or lung disease - You require continuous oxygen - You have a large amount of body fat under the skin that would interfere with the light sensor readings Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Prisma Health Cancer Institute

Greenville, South Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06672497


Related Trials